BOSTON: A subsidiary of India’s Manipal Education and Medical Group is expected to be set up in Malaysia to focus on stem cell research and development.
It is also part of a plan to explore potential collaboration between the Manipal Group and Malaysian companies.
A memorandum of understanding for this purpose will be signed between Malaysian Biotechnology Corporation and the Manipal Group tonight.
It will be witnessed by Deputy Prime Minister Datuk Seri Najib Tun Razak, who is here for the annual BIO International Convention which ends on Wednesday.
Another significant MoU will be between Massachusetts Institute of Technology and the National Biotechnology Division of the Science, Technology and Innovation Ministry.
Both parties are to research the development of science and technology in the manufacture of bio-plastics in Malaysia.
These are among the 11 MoUs to be inked between Malaysian companies and foreign biotech firms.
Another agreement involves Inno Biologics Sdn Bhd, which will work with one of the world’s top 20 pharmaceutical firms to research, develop and market human pharmaceuticals and animal health products.
This 10-year cooperation with Boehringer Ingelheim of Germany will allow Inno Biologics to have access to its technology for the manufacturing of biopharmaceutical products.
Malaysian Genomics Resource Centre will sign an MoU with 454 Life Sciences Corporation, a US company, to promote the use of the latest genomic technologies in Malaysia.
Taiwan’s biggest herbal enzyme manufacturer, meanwhile, will work with 1st Global Biotech (M) Sdn Bhd towards setting up a joint venture firm to conduct research and commercialisation of new biotechnology products.